MENU
KPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kiora Pharmaceuticals (KPRX) Earnings Date & Reports

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases... Show more

A.I. Advisor
published Earnings

KPRX is expected to report earnings to rise 52.94% to -51 cents per share on November 06

Kiora Pharmaceuticals KPRX Stock Earnings Reports
Q3'26
Est.
$-0.52
Q2'26
Beat
by $0.17
Q1'26
Missed
by $0.09
Q4'25
Missed
by $1.50
Q3'25
Beat
by $0.07
The last earnings report on August 07 showed earnings per share of -34 cents, beating the estimate of -50 cents. With 716.00 shares outstanding, the current market capitalization sits at 11.86M.
View a ticker or compare two or three
KPRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products to treat eye diseases

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
332 Encinitas Boulevard
Phone
+1 858 224-9600
Employees
12
Web
https://www.kiorapharma.com